These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37395989)

  • 21. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
    Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
    Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laryngeal adenocarcinoma not otherwise specified: A population-based perspective.
    Spinazzi EF; Abboud MT; Dubal PM; Verma SP; Park RC; Baredes S; Eloy JA
    Laryngoscope; 2017 Feb; 127(2):424-429. PubMed ID: 27140822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.
    Bochtler T; Reiling A; Endris V; Hielscher T; Volckmar AL; Neumann O; Kirchner M; Budczies J; Heukamp LC; Leichsenring J; Allgäuer M; Kazdal D; Löffler H; Weichert W; Schirmacher P; Stenzinger A; Krämer A
    Int J Cancer; 2020 Jun; 146(11):3053-3064. PubMed ID: 31970771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature.
    Overby A; Duval L; Ladekarl M; Laursen BE; Donskov F
    Clin Genitourin Cancer; 2019 Feb; 17(1):e32-e37. PubMed ID: 30268423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
    Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinoma of unknown primary: retrospective study of 437 patients treated at Salah Azaiez Institute.
    Fehri R; Rifi H; Alboueiri A; Malouche D; Ayadi M; Rais H; Mezlini A
    Tunis Med; 2013 Mar; 91(3):205-8. PubMed ID: 23588636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinomas of an unknown primary origin--diagnosis and treatment.
    Massard C; Loriot Y; Fizazi K
    Nat Rev Clin Oncol; 2011 Nov; 8(12):701-10. PubMed ID: 22048624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical presentation of carcinoma of unknown primary: 14 years of experience.
    Yi JH; La Choi Y; Lee SJ; Ahn HK; Baek KK; Lim T; Lee DJ; Han BR; Lee HY; Jun HJ; Lee J; Park YH
    Tumour Biol; 2011 Feb; 32(1):45-51. PubMed ID: 20697986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic metastases from carcinomas of unknown primary site.
    Pouessel D; Thezenas S; Culine S; Becht C; Senesse P; Ychou M
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1224-32. PubMed ID: 16518276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of outcomes between rectal squamous cell carcinoma and adenocarcinoma.
    Chiu MS; Verma V; Bennion NR; Bhirud AR; Li J; Charlton ME; Are C; Lin C
    Cancer Med; 2016 Dec; 5(12):3394-3402. PubMed ID: 27781400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine carcinoma of unknown primary: a systematic review of the literature and a comparative study with other neuroendocrine tumors.
    Stoyianni A; Pentheroudakis G; Pavlidis N
    Cancer Treat Rev; 2011 Aug; 37(5):358-65. PubMed ID: 21481536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait.
    Huey RW; Makawita S; Xiao L; Matamoros A; Estrella JS; Overman MJ; Varadhachary GR; Raghav K
    BMC Cancer; 2019 Oct; 19(1):965. PubMed ID: 31623602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study.
    Zhu J; Liang X; Wu D; Chen S; Yang B; Mao W; Shen D
    Medicine (Baltimore); 2021 Apr; 100(15):e25237. PubMed ID: 33847621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer.
    Young JI; Mongoue-Tchokote S; Wieghard N; Mori M; Vaccaro GM; Sheppard BC; Tsikitis VL
    Dis Colon Rectum; 2016 Apr; 59(4):306-15. PubMed ID: 26953989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?
    Lenzi R; Hess KR; Abbruzzese MC; Raber MN; Ordoñez NG; Abbruzzese JL
    J Clin Oncol; 1997 May; 15(5):2056-66. PubMed ID: 9164218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies.
    Ou SH; Zell JA
    J Thorac Oncol; 2009 Oct; 4(10):1202-11. PubMed ID: 19701111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of cytoreductive surgery on outcomes of metastatic appendiceal carcinoma: a real-world, population-based study.
    Abdel-Rahman O
    J Comp Eff Res; 2020 Apr; 9(6):431-439. PubMed ID: 32253936
    [No Abstract]   [Full Text] [Related]  

  • 38. Surgery to the primary tumor is associated with improved survival of patients with metastatic esophageal cancer: propensity score-matched analyses of a large retrospective cohort.
    Zhang R; Zou J; Li P; Li Q; Qiao Y; Han J; Huang K; Ruan P; Lin H; Song Q; Fu Z
    Dis Esophagus; 2020 Mar; 33(3):. PubMed ID: 31175353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of metastatic neoplasms with unknown primary.
    Bochtler T; Löffler H; Krämer A
    Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unknown primary adenocarcinomas: a single-center experience.
    Uzunoglu S; Erdogan B; Kodaz H; Cinkaya A; Turkmen E; Hacibekiroglu I; Sari A; Ozen A; Usta U; Cicin I
    Bosn J Basic Med Sci; 2016 Nov; 16(4):292-297. PubMed ID: 27455119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.